Johns Hopkins University School of Medicine, Baltimore, Maryland.
Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore, Maryland.
Cancer Immunol Res. 2017 Dec;5(12):1058-1061. doi: 10.1158/2326-6066.CIR-17-0590.
The FDA-AACR Oncology Dose-Finding Workshop, Part 3, was held in Washington, DC, on July 20, 2017, as a continuation of the previous two collaborative dose-finding and optimization workshops presented by the FDA and AACR. This year's workshop focused on combination therapy with immune-oncology agents and best practices regarding patient and dose selection, predictive biomarkers, and novel clinical endpoints. This summary highlights viewpoints that emerged during the workshop. .
美国食品药品监督管理局-美国癌症研究协会肿瘤剂量发现研讨会第三部分于 2017 年 7 月 20 日在华盛顿特区举行，是前两届由美国食品药品监督管理局和美国癌症研究协会联合举办的协作剂量发现和优化研讨会的延续。今年的研讨会重点关注免疫肿瘤药物的联合治疗以及关于患者和剂量选择、预测生物标志物和新的临床终点的最佳实践。本摘要重点介绍了研讨会期间出现的观点。
